NASDAQ
UG

United-Guardian Inc

Household & Personal Products
Consumer Defensive

Prices are adjusted according to historical splits.

United-Guardian Inc Stock Price

Vitals

Today's Low:
$7.54
Today's High:
$7.6201
Open Price:
$7.54
52W Low:
$7.1551
52W High:
$14.0825
Prev. Close:
$7.61
Volume:
2082

Company Statistics

Market Cap.:
$34.96 million
Book Value:
2.282
Revenue TTM:
$10.40 million
Operating Margin TTM:
25.8%
Gross Profit TTM:
$6.70 million
Profit Margin:
21.56%
Return on Assets TTM:
14.24%
Return on Equity TTM:
22.25%

Company Profile

United-Guardian Inc had its IPO on 1992-03-17 under the ticker symbol UG.

The company operates in the Consumer Defensive sector and Household & Personal Products industry. United-Guardian Inc has a staff strength of 23 employees.

Stock update

Shares of United-Guardian Inc opened at $7.54 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $7.54 - $7.62, and closed at $7.62.

This is a +0.13% increase from the previous day's closing price.

A total volume of 2,082 shares were traded at the close of the day’s session.

In the last one week, shares of United-Guardian Inc have slipped by -4.75%.

United-Guardian Inc's Key Ratios

United-Guardian Inc has a market cap of $34.96 million, indicating a price to book ratio of 5.1718 and a price to sales ratio of 3.7237.

In the last 12-months United-Guardian Inc’s revenue was $10.40 million with a gross profit of $6.70 million and an EBITDA of $2.80 million. The EBITDA ratio measures United-Guardian Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, United-Guardian Inc’s operating margin was 25.8% while its return on assets stood at 14.24% with a return of equity of 22.25%.

In Q2, United-Guardian Inc’s quarterly earnings growth was a negative -27.2% while revenue growth was a negative 26.9%.

United-Guardian Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
15.8542
PEG
0

Its diluted EPS in the last 12-months stands at $0.48 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into United-Guardian Inc’s profitability.

United-Guardian Inc stock is trading at a EV to sales ratio of 3.2821 and a EV to EBITDA ratio of 9.1247. Its price to sales ratio in the trailing 12-months stood at 3.7237.

United-Guardian Inc stock pays annual dividends of $0.41 per share, indicating a yield of 5.28% and a payout ratio of 83.64%.

Balance sheet and cash flow metrics

Total Assets
$11.88 million
Total Liabilities
$1.35 million
Operating Cash Flow
$4.85 million
Capital Expenditure
$1330
Dividend Payout Ratio
83.64%

United-Guardian Inc ended 2024 with $11.88 million in total assets and $0 in total liabilities. Its intangible assets were valued at $11.88 million while shareholder equity stood at $10.48 million.

United-Guardian Inc ended 2024 with $0 in deferred long-term liabilities, $1.35 million in other current liabilities, 459432.00 in common stock, $10.02 million in retained earnings and $0 in goodwill. Its cash balance stood at $6.48 million and cash and short-term investments were $7.42 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

United-Guardian Inc’s total current assets stands at $11.36 million while long-term investments were $0 and short-term investments were $939576.00. Its net receivables were $1.54 million compared to accounts payable of $155842.00 and inventory worth $1.78 million.

In 2024, United-Guardian Inc's operating cash flow was $4.85 million while its capital expenditure stood at $1330.

Comparatively, United-Guardian Inc paid $0.84 in dividends in 2024.

Other key metrics

Current Trading Price
$7.62
52-Week High
$14.0825
52-Week Low
$7.1551
Analyst Target Price
$

United-Guardian Inc stock is currently trading at $7.62 per share. It touched a 52-week high of $14.0825 and a 52-week low of $14.0825. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $7.82 and 200-day moving average was $9.51 The short ratio stood at 0.71 indicating a short percent outstanding of 0%.

Around 3638.6% of the company’s stock are held by insiders while 2244.2% are held by institutions.

Frequently Asked Questions About United-Guardian Inc

The stock symbol (also called stock or share ticker) of United-Guardian Inc is UG

The IPO of United-Guardian Inc took place on 1992-03-17

Similar Industry Stocks (Household & Personal Products)

Last Price
Chg
Chg%
$1498.7
-38.7
-2.52%
$78.74
-0.53
-0.67%
$8.51
0
+0.05%
$26.4
-1.38
-4.97%
$3.48
-0.68
-16.3%
$56.24
-5.9
-9.49%
$15.49
0.21
+1.37%
$0.82
-0.02
-2.4%
$129.4
-5.95
-4.4%
$10.12
0.02
+0.2%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company’s pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. The company was founded in 1942 and is based in Hauppauge, New York.

Address

230 Marcus Boulevard, Hauppauge, NY, United States, 11788